XFLH Capital Corporation entered into a non-binding letter of intent with Renogen Biolab Inc. for a proposed business combination on September 18, 2026. The parties agreed to negotiate definitive agreements in good faith and conduct due diligence. XFLH Capital Corporation is a special purpose acquisition company formed under the laws of the Cayman Islands.
